Assignee
SHANGHAI FOCHON PHARMACEUTICAL CO LTD
CN·12 granted patents·1 pending application·9 citations·filing 2013–2017
Top patents by PatentIndex Score
13 records- 0177US9714235B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 25, 2017·3 cites·2 claims
- 0273US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0373US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0471US9556171B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2014·Granted Jan 31, 2017·2 cites·15 claims
- 0547US10053449B2Quinazoline derivatives, compositions thereof, and use as pharmaceuticalsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Aug 21, 2018·0 cites·3 claims
- 0646US10835535B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 17, 2020·0 cites·17 claims
- 0745US10022374B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 17, 2018·0 cites·13 claims
- 0842US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 0940US2015284385A1Certain dipeptidyl peptidase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1039US11168078B2Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenaseSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 9, 2021·0 cites·17 claims
- 1137US10800785B2Substituted pyrrolo[2,3-d]pyridazin-4-ones and pyrazolo[3,4-d]pyridazin-4-ones as protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 13, 2020·0 cites·18 claims
- 1236US10894038B2Indolizine derivatives, composition and methods of useSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·20 claims
- 1333US10328060B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 25, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when SHANGHAI FOCHON PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →